Buscar en
Enfermedades Infecciosas y Microbiología Clínica (English Edition)
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica (English Edition) Parvimonas micra infective endocarditis
Journal Information
Vol. 38. Issue 9.
Pages 449-450 (November 2020)
Share
Share
Download PDF
More article options
Vol. 38. Issue 9.
Pages 449-450 (November 2020)
Scientific letter
DOI: 10.1016/j.eimce.2020.01.011
Full text access
Parvimonas micra infective endocarditis
Endocarditis infecciosa por Parvimonas micra
Visits
...
Marta García-Hitaa,
Corresponding author
Marta.garhit@gmail.com

Corresponding author.
, Ignacio Antonio Sigona-Giangrecoa, Alejandro Rincón-Almanzab, Juan Frasquet-Artesa
a Servicio de Microbiología, Hospital Universitario y Politécnico la Fe, Valencia, Spain
b Servicio de Cirugía Cardiovascular, Hospital Universitario y Politécnico la Fe, Valencia, Spain
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Full Text

Parvimonas micra, formerly Peptostreptococcus micros and Micromonas micros, are anaerobic, gram-positive cocci that belong to the abdominal, oropharyngeal and genitourinary flora, commonly related with periodontal diseases.1 Its pathogenicity has been also documented in disseminated diseases such as septic arthritis, spondylodiscitis or abscesses in different organs.2–4 In 2015 the first case of endocarditis was described, in a 71-years-old male patient with valve abscess.1 A literature review showed two cases of infectious endocarditis due to P.micra1,5 and three cases related to their ancestor P. micros.6–8

We present a case of infectious endocarditis in a woman with a pacemaker and prosthetic mitral valve.

A 63-year-old female presented at the emergency department with a history of one month of persistent fever at dawn and noon, with chills, diaphoresis, asthenia and weight loss (5kg). She denied dental procedures, recent interventions or invasive diagnostic techniques. Oral evaluation was made with no signs of periodontal disease other than edentulism. There were no respiratory, gastrointestinal, musculoskeletal or urinary symptoms and no cutaneous manifestation were found.

She had frequent follow-ups with neurosurgery and neurology for a right cerebral subependymoma and a mid-cerebral artery cardioembolic ictus performed eleven months prior to this episode. She had had a mechanical prosthetic mitral valve replacement in 1990. She had frequent checkups with urology for kidney angiomyolipomas.

On examination, temperature was normal, blood pressure was 130/62mmHg, pulse of 70 beats per minute, respiratory rate of 18 breaths per minute, and oxygen saturation 100%. Auscultation was clear with no remarkable finding except for a click in the mitral valve. No lymphadenopathies were noted, as well as no edemas, with low muscle mass. The remainder examination was normal.

The patient was hospitalized to study a fever of unknown origin, and an echocardiography and positron emission tomography/computed tomography (PET/CT) were done. The PET/CT showed metabolic signs of infection in mitral prosthetic and periprosthetic tissue with moderate increased tracer uptake at the right carotid artery, aortic arch, thoracic aorta and pulmonary arteries compatible with active vasculitis on the large vessels. No pacemaker or extracardiac deposites were found.

A Transesophageal echocardiography (TEE) showed a vegetation on the medial side of the prosthetic ring of about 8mm (Fig. 1). Cardiac and aortic CT discarded the possibility of valvular abscess or aortitis.

Fig. 1.

Transesophageal echocardiography, shows vegetation on the medial side of the prosthetic ring of about 8mm.

(0.18MB).

During the first 5 days of hospitalization 3 blood cultures were taken and incubated in BACT/ALERT® VIRTUO® (bioMérieux). After 43.94h of average incubation (44.88h – 42.82h – 44.13h) in the anaerobic media growth of gram-positive cocci identified by MALDI-TOF® as P. micra. The antibiotic susceptibility was done using Epsilon test in Columbia blood agar supplemented with 5% lamb defibrinated blood, in anaerobic atmosphere, obtaining the following MIC (mg/L) profile: penicillin 0.016, ampicillin 0.032, amoxicillin-clavulanic 0.047, ceftriaxone 0.125, imipenem 0.012, clindamycin 0.094, vancomycin 0.38, levofloxacin 0.19, rifampicin 0.002.

Empiric treatment was started with ceftriaxone and gentamycin and later modified to penicillin and clindamycin after culture isolation. The first negative blood culture was 4 days after initial treatment. TEE showed vegetation stability without complications, so it was decided to manage the case conservatively, with outpatient orally treatment with ceftriaxone and rifampicin for 6 more weeks. The evolution was favorable with negative control of blood cultures up to one year after the episode. After a year follow up by the Rheumatology Department the conclusion was that, findings on the PET/CT scan were due to the inflammatory response to the infection, which diminished on subsequent scans.

Endocarditis is mainly caused by species of the genus Streptococcus and Staphylococcus, comprising around two-thirds of the total of infectious endocarditis, while anaerobic organisms are only isolated in 2–16% of the cases.9 Predominant anaerobic species are Cutibacterium acnes, Bacteroides fragilis and Clostridium spp.10 Endocarditis due to Peptostreptococcus spp. are infrequent10 with P. magnus being the most common species.9 If we focus on P. micra, until now five cases have been described in the literature,1,5–8 only two of them encompassed within this terminology.1,5

Conflict of interest

None.

References
[1]
C.A. Gomez, D.A. Gerber, E. Zambrano, N. Banaei, S. Deresinski, B.G. Blackburn.
First case of infectious endocarditis caused by Parvimonas micra.
[2]
H. Uemura, K. Hayakawa, K. Shimada, M. Tojo, M. Nagamatsu, T. Miyoshi-Akiyama, et al.
Parvimonas micra as a causative organism of spondylodiscitis: a report of two cases and a literature review.
Int J Infect Dis, 23 (2014), pp. 53-55
[3]
S. Gupta, A. Baghban.
Parvimonas micra: a rare cause of native joint septic arthritis.
[4]
E.Y. Kim, Y.H. Baek.
Concomitant liver and brain abscesses caused by Parvimonas micra.
Korean J Gastroenterol, 73 (2019), pp. 230-234
[5]
D. Ho, G. Ang, C. Er, S.F. Yap, V.M. Aravamudan.
An unusual presentation of Parvimonas micra infective endocarditis.
Cureus, 10 (2018), pp. e3447
[6]
P. Ubeda, J. Todoli, S. Saro, M.D. Gómez, C. Pérez Bellés, M. Gobernado.
Endocarditis infecciosa subaguda sobre válvula protésica por Peptostreptococcus micros.
Enferm Infecc Microbiol Clin, 16 (1998), pp. 101-102
[7]
C. Wenisch, E. Wiesinger, T. Werkgartner, A. Makristathis, W. Graninger.
Treatment of Peptostreptococcus micros endocarditis with teicoplanin.
Clin Infect Dis, 21 (1995), pp. 446-447
[8]
A. Bassa Malondra, M. García Gasalla, A. Cladera, M. Garau.
Peptostreptococcus endocarditis: presentation of two cases and literature review.
An Med Interna, 25 (2008), pp. 226-228
[9]
R. Pathak, A. Ngwe, H. Enuh, J. Saverimuttu.
Peptostreptococcus induced native-valve endocarditis.
J Infect Dis, 12 (2013), pp. 1-3
[10]
N. Fernández-Hidalgo, P. Tornos Mas.
Epidemiology of infective endocarditis in spain in the last 20 years.
Rev Esp Cardiol, 66 (2013), pp. 728-733
Copyright © 2020. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos